IARTIntegra Lifesciences Holdings Corp
Earnings
When Integra Lifesciences Holdings Corp reports, what it reported each quarter, and how the stock took the results.
70 quarters. Jun 30, 2009 to Sep 30, 2026. USD.
Next results · Q4 2026Projected
Feb 25, before the open
Thu, Feb 25, 2027in 100 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Feb 19 – Mar 1
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- $434.93M
- Revenue, change from a year earlier: Q3 2026 +2.3%, Q2 2026 +0.8%, Q1 2026 +2.4%, Q4 2025 −1.7%
- Net income
- -$1.70M
- Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m
Latest results
- Revenue
- $411.18M
- +2.3%
- Net income
- $14.85M
- N/M
- EPS
- $0.19
- N/M
- Revenue
- $418.76M
- +0.8%
- Net income
- $4.48M
- N/M
- EPS
- $0.06
- N/M
- Revenue
- $391.92M
- +2.4%
- Net income
- -$4.62M
- N/M
- EPS
- -$0.06
- N/M
- Revenue
- $434.93M
- −1.7%
- Net income
- -$1.70M
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Oct 21, 2026 · pre-market | Oct 23, 2026 | 23 d | 10-Q | $411.18M | +2.3% | $0.19 | 11.0% | |
| Q2 2026 | Jun 30, 2026 | Jul 29, 2026 · pre-market | Jul 29, 2026 | 29 d | 10-Q | $418.76M | +0.8% | $0.06 | 16.5% | |
| Q1 2026 | Mar 31, 2026 | May 5, 2026 · pre-market | May 5, 2026 | 35 d | 10-Q | $391.92M | +2.4% | -$0.06 | +24.1% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Feb 26, 2026 · pre-market | Feb 26, 2026 | 57 d | 10-K | $434.93M | −1.7% | — | 2.2% | |
| Q3 2025 | Sep 30, 2025 | Oct 30, 2025 · pre-market | Oct 30, 2025 | 30 d | 10-Q | $402.06M | +5.6% | -$0.07 | 23.5% | |
| Q2 2025 | Jun 30, 2025 | Jul 31, 2025 · pre-market | Jul 31, 2025 | 31 d | 10-Q | $415.61M | −0.6% | -$6.31 | +6.1% | |
| Q1 2025 | Mar 31, 2025 | May 5, 2025 · pre-market | May 5, 2025 | 35 d | 10-Q | $382.65M | +3.7% | -$0.33 | 21.0% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Feb 25, 2025 · pre-market | Feb 25, 2025 | 56 d | 10-K | $442.65M | +11.5% | — | +12.1% | |
| Q3 2024 | Sep 30, 2024 | Nov 4, 2024 · pre-market | Nov 4, 2024 | 35 d | 10-Q | $380.83M | −0.4% | -$0.14 | +25.2% | |
| Q2 2024 | Jun 30, 2024 | Jul 29, 2024 · pre-market | Jul 29, 2024 | 29 d | 10-Q | $418.18M | +9.7% | -$0.16 | 20.3% | |
| Q1 2024 | Mar 31, 2024 | May 6, 2024 · pre-market | May 6, 2024 | 36 d | 10-Q | $368.87M | −3.1% | -$0.04 | — | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Feb 28, 2024 · pre-market | Feb 28, 2024 | 59 d | 10-K | $397.04M | −0.2% | — | 13.5% | |
| Q3 2023 | Sep 30, 2023 | Oct 25, 2023 · pre-market | Oct 25, 2023 | 25 d | 10-Q | $382.42M | −0.7% | $0.24 | — | |
| Q2 2023 | Jun 30, 2023 | Jul 26, 2023 · after-hours | Jul 27, 2023 | 27 d | 10-Q | $381.27M | −4.2% | $0.05 | 0.4% | |
| Q1 2023 | Mar 31, 2023 | Apr 26, 2023 · pre-market | Apr 26, 2023 | 26 d | 10-Q | $380.85M | +1.1% | $0.29 | 6.9% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Feb 22, 2023 · pre-market | Feb 22, 2023 | 53 d | 10-K | $398.02M | −1.8% | — | — | |
| Q3 2022 | Sep 30, 2022 | Oct 26, 2022 · pre-market | Oct 26, 2022 | 26 d | 10-Q | $385.19M | −0.4% | $0.60 | — | |
| Q2 2022 | Jun 30, 2022 | Jul 27, 2022 · pre-market | Jul 27, 2022 | 27 d | 10-Q | $397.82M | +2.0% | $0.54 | — | |
| Q1 2022 | Mar 31, 2022 | Apr 27, 2022 · pre-market | Apr 27, 2022 | 27 d | 10-Q | $376.64M | +4.6% | $0.39 | +0.9% | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | Feb 23, 2022 · pre-market | Feb 24, 2022 | 55 d | 10-K | $405.52M | +4.3% | — | +0.9% | |
| Q3 2021 | Sep 30, 2021 | Nov 2, 2021 · pre-market | Nov 2, 2021 | 33 d | 10-Q | $386.86M | +4.5% | $0.51 | — | |
| Q2 2021 | Jun 30, 2021 | Jul 28, 2021 · pre-market | Jul 29, 2021 | 29 d | 10-Q | $389.99M | +50.8% | $0.41 | +5.7% | |
| Q1 2021 | Mar 31, 2021 | Apr 28, 2021 · pre-market | Apr 29, 2021 | 29 d | 10-Q | $360.07M | +1.6% | $0.53 | 3.3% | |
| FY 2020 | ||||||||||
| Q4 2020 | Dec 31, 2020 | Feb 18, 2021 · pre-market | Feb 23, 2021 | 54 d | 10-K | $388.65M | −1.6% | $1.09 | — | |
| Q3 2020 | Sep 30, 2020 | Oct 28, 2020 · pre-market | Oct 29, 2020 | 29 d | 10-Q | $370.23M | −2.3% | $0.38 | 7.1% | |
| Q2 2020 | Jun 30, 2020 | Aug 10, 2020 · after-hours | Aug 10, 2020 | 41 d | 10-Q | $258.67M | −32.6% | $0.00 | +6.6% | |
| Q1 2020 | Mar 31, 2020 | May 7, 2020 · pre-market | May 7, 2020 | 37 d | 10-Q | $354.32M | −1.5% | $0.11 | +2.0% | |
| FY 2019 | ||||||||||
| Q4 2019 | Dec 31, 2019 | Feb 19, 2020 · pre-market | Feb 21, 2020 | 52 d | 10-K | $395.13M | +3.1% | $0.18 | — | |
| Q3 2019 | Sep 30, 2019 | Oct 24, 2019 · pre-market | Oct 25, 2019 | 25 d | 10-Q | $379.10M | +3.6% | -$0.32 | — | |
| Q2 2019 | Jun 30, 2019 | Jul 24, 2019 · pre-market | Jul 25, 2019 | 25 d | 10-Q | $383.65M | +4.8% | $0.34 | — | |
| Q1 2019 | Mar 31, 2019 | — | Apr 29, 2019 | 29 d | 10-Q | $359.69M | +0.7% | $0.38 | — | |
| FY 2018 | ||||||||||
| Q4 2018 | Dec 31, 2018 | — | Feb 26, 2019 | 57 d | 10-K | $383.32M | +4.0% | $0.29 | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 1, 2018 | 32 d | 10-Q | $365.85M | +31.2% | $0.15 | 12.8% | |
| Q2 2018 | Jun 30, 2018 | — | Jul 26, 2018 | 26 d | 10-Q | $366.19M | +29.8% | $0.14 | +1.5% | |
| Q1 2018 | Mar 31, 2018 | — | Apr 26, 2018 | 26 d | 10-Q | $357.08M | +38.1% | $0.14 | +11.7% | |
| FY 2017 | ||||||||||
| Q4 2017 | Dec 31, 2017 | — | Mar 1, 2018 | 60 d | 10-K | $368.60M | +44.2% | $0.56 | +0.7% | |
| Q3 2017 | Sep 30, 2017 | — | Oct 26, 2017 | 26 d | 10-Q | $278.83M | +11.4% | $0.04 | 2.5% | |
| Q2 2017 | Jun 30, 2017 | — | Jul 26, 2017 | 26 d | 10-Q | $282.16M | +13.2% | $0.14 | +0.4% | |
| Q1 2017 | Mar 31, 2017 | — | Apr 26, 2017 | 26 d | 10-Q | $258.64M | +9.2% | $0.08 | — | |
| FY 2016 | ||||||||||
| Q4 2016 | Dec 31, 2016 | — | Feb 23, 2017 | 54 d | 10-K | $255.66M | +6.0% | $0.35 | — | |
| Q3 2016 | Sep 30, 2016 | — | Oct 28, 2016 | 28 d | 10-Q | $250.33M | +10.6% | $0.25 | +6.0% | |
| Q2 2016 | Jun 30, 2016 | — | Jul 28, 2016 | 28 d | 10-Q | $249.31M | +17.2% | $0.16 | +1.6% | |
| Q1 2016 | Mar 31, 2016 | — | Apr 27, 2016 | 27 d | 10-Q | $236.77M | +16.9% | $0.18 | — | |
| FY 2015 | ||||||||||
| Q4 2015 | Dec 31, 2015 | — | Feb 26, 2016 | 57 d | 10-K | $241.16M | +10.1% | $0.20 | 0.0% | |
| Q3 2015 | Sep 30, 2015 | — | Nov 4, 2015 | 35 d | 10-Q | $226.37M | +14.6% | -$0.45 | +0.5% | |
| Q2 2015 | Jun 30, 2015 | — | Jul 31, 2015 | 31 d | 10-Q | $212.67M | −8.1% | $0.08 | 0.1% | |
| Q1 2015 | Mar 31, 2015 | — | May 1, 2015 | 31 d | 10-Q | $202.53M | −5.8% | $0.13 | +11.4% | |
| FY 2014 | ||||||||||
| Q4 2014 | Dec 31, 2014 | — | Feb 27, 2015 | 58 d | 10-K | $219.07M | −0.8% | $0.52 | +3.2% | |
| Q3 2014 | Sep 30, 2014 | — | Nov 7, 2014 | 38 d | 10-Q | $197.52M | −7.4% | $0.30 | +0.3% | |
| Q2 2014 | Jun 30, 2014 | — | Aug 5, 2014 | 36 d | 10-Q | $231.35M | +12.6% | $0.15 | +3.9% | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | $215.06M | +9.4% | $0.07 | — | |
| FY 2013 | ||||||||||
| Q4 2013 | Dec 31, 2013 | — | — | — | — | $220.77M | +3.0% | $0.45 | — | |
| Q3 2013 | Sep 30, 2013 | — | — | — | — | $213.25M | +1.5% | -$1.09 | — | |
| Q2 2013 | Jun 30, 2013 | — | — | — | — | $205.55M | −2.2% | $0.05 | — | |
| Q1 2013 | Mar 31, 2013 | — | — | — | — | $196.65M | +0.2% | -$0.22 | — | |
| FY 2012 | ||||||||||
| Q4 2012 | Dec 31, 2012 | — | — | — | — | $214.43M | +5.4% | $0.46 | — | |
| Q3 2012 | Sep 30, 2012 | — | — | — | — | $210.08M | +3.9% | $0.46 | — | |
| Q2 2012 | Jun 30, 2012 | — | — | — | — | $210.17M | +8.7% | $0.30 | — | |
| Q1 2012 | Mar 31, 2012 | — | — | — | — | $196.19M | +8.4% | $0.23 | — | |
| FY 2011 | ||||||||||
| Q4 2011 | Dec 31, 2011 | — | — | — | — | $203.52M | +4.8% | $0.16 | — | |
| Q3 2011 | Sep 30, 2011 | — | — | — | — | $202.19M | +8.3% | $0.39 | — | |
| Q2 2011 | Jun 30, 2011 | — | — | — | — | $193.33M | +8.2% | $0.02 | — | |
| Q1 2011 | Mar 31, 2011 | — | — | — | — | $181.04M | +4.8% | $0.38 | — | |
| FY 2010 | ||||||||||
| Q4 2010 | Dec 31, 2010 | — | — | — | — | $194.13M | — | $0.63 | — | |
| Q3 2010 | Sep 30, 2010 | — | — | — | — | $186.64M | +8.3% | $0.55 | — | |
| Q2 2010 | Jun 30, 2010 | — | — | — | — | $178.60M | +7.8% | $0.50 | — | |
| Q1 2010 | Mar 31, 2010 | — | — | — | — | $172.70M | — | $0.50 | — | |
| FY 2009 | ||||||||||
| Q4 2009derived | Dec 31, 2009 | — | — | — | — | — | — | — | — | |
| Q3 2009 | Sep 30, 2009 | — | — | — | — | $172.29M | — | $0.49 | — | |
| Q2 2009 | Jun 30, 2009 | — | — | — | — | $165.73M | — | $0.38 | — | |
Earlier years, FY 2009 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR